Clinical trials
Withdrawn Multiple Sclerosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 2 |
| Ageless Regenerative Institute | 1 |
| Boston Children's Hospital | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Genetic Disease Investigators | 1 |
| Healeon Medical Inc | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Jagannadha R Avasarala | 1 |
| Louisiana State University Health Sciences Center in New Orleans | 1 |
| Loxo Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 35 |
| Fatigue | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Autoimmune Diseases | 2 |
| Demyelinating Diseases | 2 |
| Nervous System Diseases | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Cognitive Dysfunction | 1 |
| Erectile Dysfunction | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.